Full-thickness human skin-on-chip research and first stem cells using CRISPR genome activation
Get all updates at the 3D Cell Culture Conference, 21 - 22nd February 2018, London, UK
Novartis has struck another deal to build its position in radiopharmaceuticals, agreeing to pay $1 billion upfront for radioligand therapy (RLT) developer Mariana Oncology
It’s 2024, and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen and typing it onto another.